Pemphigus encompasses a group of autoimmune blistering diseases with circulating pathogenic autoantibodies recognizing several proteins, including the desmosomal cadherin, desmoglein 3. Targeted disruption of the Dsg3 gene by homologous recombination (
Pulkkinen, L +6 more
core
Non-COVID-19 Vaccinations and the Induction of Autoantibodies in Pemphigus Diseases: A Review of the Speculative Issue and Our Clinical-Laboratory Experience. [PDF]
Markwitz M +4 more
europepmc +1 more source
IgG subclasses and their significance in pemphigus disease progression monitoring. [PDF]
Wang Y +9 more
europepmc +1 more source
Protocol to quantify desmoglein 3 tension at cell-cell adhesions using FRET-based tension sensors. [PDF]
Safa BT +5 more
europepmc +1 more source
Kallikrein related peptidases 7 and 10 and their substrate desmoglein 3 are upregulated in early stage pancreatic cancerous lesions. [PDF]
Eisenhauer J +10 more
europepmc +1 more source
Real-World Experience With Single Ultra-Low Dose Rituximab for Remission Induction in Pemphigus. [PDF]
Jeng YC, Liu WT, Hsu CK, Yang CC.
europepmc +1 more source
Toward Precision Oral Medicine in Pemphigus Vulgaris: A Conceptual AI Framework for Rituximab Response Prediction. [PDF]
Russu EA +6 more
europepmc +1 more source
Editorial: The systemic and metabolic effects of 17-beta estradiol. [PDF]
González-Flores O.
europepmc +1 more source
Rituximab remodels the circulating immune landscape in pemphigus vulgaris revealed by high-dimensional immune profiling. [PDF]
Strandmoe AL +11 more
europepmc +1 more source
Drug-Induced Pemphigus Vulgaris Following Ceftriaxone Use. [PDF]
Amadi A +4 more
europepmc +1 more source

